Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex

Journal of Neuroscience Research

Volumn 52, Issue 6, 1998, Pages 709-722

  Johnson, Kenneth M ^a   Phillips, Melissa ^a   Wang, Cheng ^a   Kevetter, Golda A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Apoptosis; Dopamine; Neurotoxicity; NMDA receptors; Olfactory tubercle; Phencyclidine; Piriform cortex; Programmed cell death; Sensitization

Indexed keywords

CLOZAPINE; GLIAL FIBRILLARY ACIDIC PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CHROMATIN CONDENSATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NONHUMAN; OLFACTORY SYSTEM; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; APOPTOSIS; BEHAVIOR, ANIMAL; CLOZAPINE; DRUG RESISTANCE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GENETIC TECHNIQUES; LIMBIC SYSTEM; MICROSCOPY, ELECTRON; MOTOR ACTIVITY; NERVE DEGENERATION; OLFACTORY PATHWAYS; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0032526647     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980615)52:6<709::AID-JNR10>3.0.CO;2-U     Document Type: Article

References (60)

1. Alagarsamy S, Phillips M, Papas T, Johnson KM (1997): Dopamine neurotoxicity in cortical neurons. Drug Alcohol Depend 48:105-111.
2. Allen RM, Young SJ (1978): Phencyclidine-induced psychosis. Am J Psychiatry 135:1081-1084.
3. Andreasen NC, Arndt S, Swayze V II, Cizadlo T, Flaum M, O'Leary D, Ehrhardt JC, Yuh WTC (1994): Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 266:294-298.
4. Ban TA, Lohrenz JJ, Lehmann HE (1961): Observations on the action of Sernyl-a new psychotropic drug. Can Psychiatr Assoc J 6:150-157.
5. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ (1993): Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons. Endocrinology 132:895-902.
6. Benes FM, Davidson J, Bird ED (1986): Quantatative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 43:31-35.
7. Benes FM, McSparren J, San-Giovanni JP, Vincent SL (1991): Deficits in small interneurons in cingulate cortex of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48:996-1001.
8. Bjorklund A, Lindvall O (1984): Dopamine-containing systems in the CNS. In Bjorklund A, Hokfelt T (eds): "Handbook of Chemical Neuroanatomy." New York, NY: Elsevier Science Publisher B.V. pp 55-122.
9. Bredesen DE (1995): Neural apoptosis. Ann Neurol 38:839-851.
10. Brown R, Colter N, Corsellis JAN, Crow TJ, Frith CD, Jagoe R, Johnstone EC, March L (1986): Postmortem evidence for structural brain changes in schizophrenia: Differences in brain weight, temporal horn area and parahippocampal gyrus width as compared with affective disorder. Arch Gen Psychiatry 43:36-42.
11. Carlin AS, Grant KM, Reed R (1979): Is phencyclidine (PCP) abuse associated with organic mental impairment? AM J Drug Alcol Abuse 6:273-281.
12. Carlsson A (1988): The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-186.
13. 1. J Pharacol Exp Ther 127:241-250.
14. Cohen BD, Rosenbaum G, Luby ED, Gottlieb JS (1962): Comparision of phencyclidine hydrochloride (Sernyl) with other drugs: Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium, II: Symbolic and sequential thinking. Arch Gen Psychiatry 6:395-401.
15. Cosgrove J, Newell TG (1991): Recovery of neuropsychological functions during reduction in use of phencyclidine. J Clinc Psych 47:159-169.
16. Coward DM (1992): General pharmacology of clozapine. Br J Psychiatry 160:5-11.
17. Ellison G (1994): Competitive and noncompetitive NMDA antagonists induce similar limbic degeneration. Neuroreport 5:2688-2692.
18. Ellison G (1995): The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res-Brain Res Rev 20:250-267.
19. Ellison G, Switzer RC (1993): Dissimilar patterns of degeneration in brain following four different addictive stimulants. Neuroreport 5:17-20.
20. Fix AS (1994): Pathological effects of MK-801 in the rat posterior cingulate/retrosplenial cortex. Psychopharmacol Bull 30:577-583.
21. Fix AS, Horn JW, Wightman KA, Johnson CA, Long GC, Storts RW, Farber NB, Wozniak DF, Olney JW (1993): Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-dl-aspartate (NMDA) antagonist MK (+)801 (dizocipline maleate): A light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 123:204-215.
22. Fix AS, Wozniak DF, Lewis TL, McEwen M, Miller JP, Olney JW (1995): Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/ retrosplenial cortex. Brain Res 696:194-204.
23. Freeman AS, Bunney BS (1984): The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur J Pharmacol 104:287-293.
24. 10 dopamine neurons in the rat. Neuropharmacology 25:241-248.
25. 10 dopamine neurons. Neurosci Lett 119:159-162.
26. Friedman BL, Price JL (1986a): Plasticity in the olfactory cortex: Age dependent effects of deafferentation. J Comp Neurol 246:1-19.
27. Friedman BL, Price JL (1986b): Age-dependent cell death in olfactory cortex: Lack of transneuronal degeneration in neonates. J Comp Neurol 246:20-31.
28. Gabacchi Y, Sherman Y, Ben-Sasson SA (1992): Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
29. Gordon N (1995): Apoptosis (programmed cell death) and other reasons for elimination of neurons and axons. Brain Dev 17:73-77.
30. Hargreaves RJ, Rigby M, Smith D, Hill RG, Iversen LL (1993): Competitive as well as noncompetitive NMDA receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism. Neurochem Res 19:1263-1269.
31. Hertel P, Mathe JM, Nomikos GG, Iurlo M, Mathe AA, Svensson TH (1996): Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav Brain Res 72:103-114.
32. Hoyt KR, Reynolds IJ, Hastings TG (1997): Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: Interactions with and differences from glutamate-induced cell death. Exp Neurol 143:269-281.
33. Javitt DC, Zukin SR (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
34. Jentsch JD, Elsworth JD, Redmond DE Jr, Roth RH (1997): Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: Modulation by the isomers of HA966. J Neurosci 17:1769-1776.
35. Johnson KM, Jones SM (1990): Neuropharmacology of phencyclidine: Basic mechanisms and therapeutic potential. Annu Rev Pharmacol Toxicol 30:707-50.
36. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995): Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19.
37. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959): Study of a new psychotropic drug-Sernyl. Arch Neurol Psychiatry 81:363-369.
38. Miller DW, Abercrombie ED (1996): Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats. Brain Res Bull 40:57-62.
39. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH (1995): Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 256:1217-1271.
40. Murray TF, Horita A (11979): Phencyclidine-induced stereotyped behavior in rats: Dose response effects and antagonism by neuroleptics. Life Sci 24:2217-2225.
41. Nabeshima T, Fukaya H, Yamaguchi K, Ishikawa K, Furukawa H, Kameyama T (1987): Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. Eur J Pharmacol 135:23-33.
42. O'Callaghan JP (1994): Biochemical analysis of glial fibrillary acidic preotein as a quantitative approach to neurotoxicity assessment: advantages, disadvantages and application to the assessment of NMDA receptor antagonist-induced neurotoxicity. Psychopharmacol Bull 30:549-54.
43. Olney J, Labruyere J, Price M (1989): Pathological changes induced in cerebrocortical neurons by phenclidine and related drugs. Science 244:1360-1362.
44. Olney JW, Labruyere J, Wang G, Sesma MA, Wozniak DF, Price MT (1991) NMDA antagonist neurotoxity: Mechanism and protection. Science 254:1515-1518.
45. Olney J, Nuri B, Farber B (1995): Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:989-1007.
46. Paxinos G, Watson C (1986): "The Rat Brain in Sereotaxic Coordinates." San Diego: Academic Press, Inc., pp 10-56.
47. Phillips M, Wang C, Leonard G, Johnson, KM (1997): Chronic phencyclidine-induced apoptosis in rat olfactory tubercle and piriform cortex: The effects of clozapine and pentobarbitol. Soc Neurosci Abst 28:2308.
48. Portera-Cailliau C, Price DL, Martin LJ (1997): Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: Further evidence for an apoptosis-necrosis continuum. J Comp Neurol 378:88-104.
49. Rabacchi SA, Bonfanti L, Liu X-H, Maffei L (1994): Apoptotic cell death induced by optic nerve lesion in the neonatal rat. J Neurosci 14:5292-5301.
50. Rao TS, Kim HS, Lehmann J, Martin LL, Wood PL (1990): Interactions of phencyclidine receptor agonist MK-801 with the dopaminergic system: Regional studies in the rat. J Neurochem 54:1157-1162.
51. Roberts GW (1990): Schizophrenia: the cellular biology of a functional psychosis. TINS 13: 207-212.
52. Sharp FR, Jasper P, Hall J, Noble L, Sagar SM (1991): MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulatc and retrosplenial cortex. Ann Neurol 30:801-809.
53. Sharp FR, Butman M, Wang S, Koistinaho J, Graham SH, Sagar SM, Noble L, Berger P, Longo FM (1992): Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine. J Neurosci Res 33:605-616.
54. Sharp FR, Butman M, Koistinaho J, Aardalen K, Nakki R, Massa SM, Swanson RA, Sagar SM (1994): Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage-gated calcium channels. Neuroscience 62:1079-1092.
55. Shenton ME, Kikinis R, Jolesz FA, Pollak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, McCarley RW (1992): Abnormalities of the left temporal lobe and thought disorder in schizophrenia: A quantitative magnetic resonance imaging study. N Engl J Med 327: 604-612.
56. 2-dopamine receptor neuron loss during aging. J Neurosci Res 47:393-399.
57. Sturgeon RD, Fessler RG, Meltzer HY (1979): Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmocol 59:169-179.
58. Xu X, Domino E (1994): Phencyclidine-induced behavioral sensitization. Pharmacol Biochem Behav 47:603-608.
59. Wolf ME, Khansa MR (1991): Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
60. Zhang X, Boulton AA, Zuo D, Yu PH (1996): MK-801 induces apoptotic neuronal death in the rat retrosplenial cortex: Prevention by cycloheximide and R(-)-2-hexyl-N-methylpropargylamine. J Neurosci Res 46:82-89.